Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

CEP-701 for PH-negative Myelofibrosis

NCT00494585

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

NCT00003005

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations: Vincent T. Lombardi Cancer Research Center, Georgetown University Washington D.C., District of Columbia, United States

Johns Hopkins Oncology Center Baltimore, Maryland, United States

New England Medical Center Hospital Boston, Massachusetts, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View all 13 locations

View Trial Details

Completed

Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia

NCT00005795

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

NCT00004230

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Safety Assessment of a Multipeptide-gene Vaccine in CML

NCT00455221

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: Hematology-Oncology & SCT Research Center Tehran, Tehran Province, Iran

View Trial Details

Completed

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

NCT00053248

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: UCLA Department of Medicine, Division of Hematology/Oncology Los Angeles, California, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

NCT00237627

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +99 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Chemotherapy in Treating Patients Who Have Hematologic Cancer

NCT00004047

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

NCT00003230

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
Locations: Kantonspital Aarau Aarau, Switzerland

Office of Walter Weber-Stadelman Basel, Switzerland

University Hospital Basel, Switzerland

Inselspital, Bern Bern, Switzerland

View Trial Details

Completed

A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies

NCT00719836

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +19 more
Locations: The University of Chicago Hospitals Chicago, Illinois, United States

MD Anderson Cancer Center Houston, Texas, United States

Fred Hutchinson Cancer Center Seattle, Washington, United States

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions